APA (7th ed.) Citation

HC, D., AB, B., DG, K., CK, G., G, O., E, C., . . . J, S. (2025). Symplocamide A as marine-derived proteasome inhibitor: A promising scaffold for targeted cancer therapy. Medical oncology (Northwood, London, England), 42(8), 351. https://doi.org/10.1007/s12032-025-02870-7

Chicago Style (17th ed.) Citation

HC, Dincturk, et al. "Symplocamide A as Marine-derived Proteasome Inhibitor: A Promising Scaffold for Targeted Cancer Therapy." Medical Oncology (Northwood, London, England) 42, no. 8 (2025): 351. https://doi.org/10.1007/s12032-025-02870-7.

MLA (9th ed.) Citation

HC, Dincturk, et al. "Symplocamide A as Marine-derived Proteasome Inhibitor: A Promising Scaffold for Targeted Cancer Therapy." Medical Oncology (Northwood, London, England), vol. 42, no. 8, 2025, p. 351, https://doi.org/10.1007/s12032-025-02870-7.